The AI data analytics company's business is still firing on all cylinders, yet its stock remains well below its 2025 peak.

The stock has surged 160% over the past three years. Meanwhile, two key drugs could continue driving rampant growth.

Shares of Nu Holdings (NU +3.12%) stock dropped 20% in the first half of 2026, according to data provided by S&P Global ...

However, the immediate reaction to Tesla stock post-earnings tends to hinge on whether the company beats or misses the ...

Insider activity at three of Wall Street's most influential artificial intelligence (AI) businesses paints a picture worth a ...

Not every credit card costs you an arm and a leg to earn solid rewards. Here are my favorite no-annual-fee options available ...

Top high-yield savings accounts are still paying up to 4.50% APY, but those yields could change as we enter the back half of ...

June IPO, Space Exploration Technologies (SPCX 0.97%) has been the market's most-discussed stock. And understandably so. Not ...

The Chase Freedom Unlimited earns flat-rate cash back with no annual fee, making it a simple first card you can hold for ...

The tech sector has been one of the hottest for growth investors, as it has a long history of outperforming the S&P 500. For ...

The first factor that caused Apple stock to fall in recent weeks stems from the company's discussions about a new version of ...

SpaceX's recent pullback may not be over, but for long-term investors, the smarter move could be changing how you buy the ...